# Very Early Versus Delayed Etanercept in Patients With RA

> **NCT02433184** · PHASE4 · COMPLETED · sponsor: **University of Leeds** · enrollment: 120 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Methotrexate
- **DRUG:** Sulfasalazine
- **DRUG:** Hydroxychloroquine
- **DRUG:** Etanercept
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT02433184
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2017-08
- **Final completion:** 2019-07
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02433184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02433184, "Very Early Versus Delayed Etanercept in Patients With RA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02433184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*